START Midwest, LLC

Running trials

• Recruiting

  A Study to Learn About the Study Medicine Called PF-08098488 in People With Advanced Solid Tumors.

  NCT07903415· Phase 1· Source

• Recruiting

  A Phase 1 Study of PRT12396 in Participants With Select Myeloproliferative Neoplasms

  NCT07469891· Phase 1· Source

• Recruiting

  A First-in-human Study of RLY-8161 in Advanced NRAS-Mutant Solid Tumors

  NCT07584226· Phase 1/2· Source

• Recruiting

  A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors

  NCT07318805· Phase 1· Source

• Recruiting

  A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors

  NCT07070232· Phase 1/2· Source

• Recruiting

  A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer

  NCT06827236· Phase 1/2· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Colorectal cancer2 recruiting
• Gastric and esophageal cancer2 recruiting
• Lung cancer2 recruiting
• Melanoma2 recruiting
• Metastatic breast cancer2 recruiting
• Myeloproliferative neoplasms1 recruiting
• Pancreatic cancer1 recruiting
• Triple-negative breast cancer1 recruiting

Researchers

No researcher is linked here yet.